Similar User
@mujhu_care_ltd
@drwendo
@CavensK
@helenmcdowell76
@Profngure
@martin_ssuuna
@Pragmatist1010
@paulkgonza
@AdefolarinYinka
@Liv_Awino
Dr. @fmatovu2 is speaking to @UMACentralb_Off about the findings of @GileadSciences PURPOSE 1 study on the twice yearly injectable Lenacapavir for PrEp. You can join the conversation here. Join Zoom Meeting us06web.zoom.us/j/81552508498?… Meeting ID: 815 5250 8498 Passcode: 655562
Workshop Highlights | MU-JHU at the International Workshop on HIV and Aging 2024 The age of people living with HIV (PWH) aged 50 years and older is on the rise, this is mainly due to advances in antiretroviral therapy (ART) that have significantly extended the lives of those…
This evening, Dr. @fmatovu2 will be hosted by Prof. Waiswa Kyobe to share the findings of @GileadSciences' Lenacapavir for PrEP HIV prevention trial drug. @mujhu_care_ltd Register here to join the conversation: busogahealthforum-org.zoom.us/meeting/regist…
Happening Tonight | Busoga Health Forum Interview Topic: Purpose 1 Study: First Phase 3 HIV Prevention Trail to Show Zero Infections. (First HIV Drug Trial to Prevent HIV Transmission) Presenter: Dr. Flavia Matovu Kiweewa, Uganda National Study Principal Investigator PURPOSE 1…
Over the course of one year, there are more than two million osteoporosis related fractures. #worldosteoporosisday #stepupforbonehealth
Bring these to your doctor’s attention, especially if you’ve had a previous fracture, have a family history of osteoporosis, or take specific medications that affect bone health. #worldosteoporosisday #stepupforbonehealth
"Eddagala teririna bulabe byonna eli abantu ela lyayita emitendera gyonna" Dr. @fmatovu2 of @Makerere @JohnsHopkins Kiweewa agumizza bannaUganda ku mpiso egema okusigibwa akawuka akaleeta mukenenya. youtu.be/Hcg-jzWu7Nc @bnamutebi @MinofHealthUG @DianaAtwine @ainbyoo
"What makes the new HIV twice yearly injectable Lenacapavir unique, is that other medicines stop at stage 1 or 2 but this one, can locate the virus at all stages" - Dr. @fmatovu2 @Makerere @JohnsHopkins @bnamutebi Explained in Luganda youtu.be/Hcg-jzWu7Nc
This is how the new HIV twice yearly injectable Lenacapavir PrEP medicine was investigated and now on the market. Dr. @fmatovu2 @Makerere @JohnsHopkins @bnamutebi @Eddmk1 Explained in Luganda youtu.be/Hcg-jzWu7Nc
#strongbones are the foundation for movement and health!
Strong bones support us, protect vital organs, and store essential minerals. Conditions like #Osteoporosis can weaken bones, making them fragile and prone to fractures. Learn how to help keep your bones healthy: bit.ly/3zwFpOp. #BoneAndJointActionWeek
This morning, On the #Uganda digital space @AlternativeUga is hosting Dr. @fmatovu2 in conversation about the twice yearly Lenacapavir for PrEP. @GileadScience @mujhu_care_ltd youtube.com/live/r7IGWNf35…
Any qn(s) about Lenacapavir for HIV Prevention, a twice year injection against catching the virus? Dr. @fmatovu2, Uganda Lead Investigator of the drug, will be joining us tomorrow on fb.com/AlternativeUga…, fb.com/DigitalkTv1 & youtube.com/@TheAlternativ… to answer all the qns.
Tune in tomorrow morning @8am on The Mighty Drive on DigiTalk Tv, as Dr. @fmatovu2 discusses the effectiveness of the new HIV twice yearly injectable Lenacapavir. Only on m.youtube.com/@TheAlternativ…
Yiino Empiso Eziyiza Mukenenya, Ab’ebyobulamu Bagikakasizza youtube.com/watch?v=OAyA5q… #HIVPrevention #PURPOSE1 #Lenacapavir
🎙️Podcast on Lenacapavir Just days before a second trial showed twice yearly injectable #LEN for PrEP to be highly efficacious, #PxPulse sat with Dr. Flavia Kiweewa, Chilufya Kasanda Hampongo and Mitchell Warren to break down the results and what’s needed to get the product to…
📢📢📢Event | PURPOSE 1 Study National Stakeholders Engagement Meeting Join us tomorrow morning for a joint review of the interim analysis results of a twice-yearly PrEP injection ( #Lenacapavir) which holds the promise of revolutionizing HIV prevention efforts. Our focus? 1.…
National Stakeholders Engagement Meeting Date: 17 September 2024 Time: 8:30 AM – 2:00 PM Contact Person: Joan Nabawanuka (Contact: 0787495156/ 0700986875). Join Zoom Meeting zoom.us/j/97670402210?…
🔥 This is a ground breaking trial highlighting Uganda' s contribution to science 🧪 over the years since the days of HIV-NET! 🔥 Transforming the way we prevent and treat HIV @mujhu_care_ltd @fmatovu2 @MJAPUg
Highlights | Media Orientation on HIV prevention, new PrEP technologies and Lenacapavir Research 📸Dr. @fmatovu2 giving updates from our ongoing #lenacapavir research - PURPOSE 1 Study. @GileadSciences @MinofHealthUG
United States Trends
- 1. Drake 275 B posts
- 2. #WWERaw 22 B posts
- 3. Chargers 35,9 B posts
- 4. Canada 393 B posts
- 5. #RavensFlock 4.128 posts
- 6. Not Like Us 70,7 B posts
- 7. Malik Harrison 1.067 posts
- 8. #BALvsLAC 3.718 posts
- 9. Jack Smith 207 B posts
- 10. Justin Herbert 4.491 posts
- 11. Hurley 9.096 posts
- 12. #BoltUp 2.762 posts
- 13. Greg Roman N/A
- 14. Gunther 4.534 posts
- 15. UConn 16,3 B posts
- 16. USMCA 1.254 posts
- 17. Memphis 28,9 B posts
- 18. Vancouver 18,9 B posts
- 19. Jim Harbaugh 2.627 posts
- 20. Jalen Reagor N/A
Who to follow
-
MU-JHU Care LTD | MU-JHU Research Collaboration
@mujhu_care_ltd -
Dr. Charles Wendo
@drwendo -
Cavens Kithinji (PhD)
@CavensK -
Helen McDowell
@helenmcdowell76 -
Peter Ngure
@Profngure -
Martin Ssuuna
@martin_ssuuna -
Jude Igumbor
@Pragmatist1010 -
Paul Gonza
@paulkgonza -
Dr Yinka Adefolarin
@AdefolarinYinka -
Olivia Awino
@Liv_Awino
Something went wrong.
Something went wrong.